The Latin America, Middle East and Africa Herpes Simplex Virus Treatment Market would witness market growth of 6.6% CAGR during the forecast period (2022-2028).
As HSV infection is more likely to reactivate in the first few months following solid organ and bone marrow transplants, the rise in the number of transplant recipients is a factor in the market's expansion. In accordance with this, researchers are concentrating on creating novel antiviral drugs to increase the range of available treatments for genital and orolabial herpes. Also, they are bringing out antiviral creams or ointments that can lessen HSV-related itching, burning, or tingling sensations, enhance the quality of life (QoL) of patients, and stop infected persons from transmitting the virus.
Many people have HSV that is asymptomatic, which means they carry the virus but have never experienced a herpes outbreak or active episode. Others may occasionally get sores or blisters that are tiny and filled with fluid. These blisters can appear on the hands, fingers, or other body parts but typically on the genitalia, mouth, or lips. The herpes virus can be spread through sexual contact, but other ways exist. Herpes carries a lot of stigmas, yet the virus is fairly widespread. As more people are becoming aware of this, the demand for HSV medication is rising.
Latin America has a high HSV-2 seroprevalence. An estimated 20% to 60% of people are infected. Middle-aged Colombian women were found to have the highest HSV-2 frequency in the region. In Brazil, women are more likely to contract HSV-2 if their male partners have a record of anal sex and have had numerous sexual partners during their lifetime. As a result, many regional governments have increased their efforts to mitigate the burden of the disease as well as increase the awareness about it among the general public. The government's provision of HSV treatment at affordable costs is among these efforts. Consequently, such efforts significantly boost the market expansion in this region.
The Brazil market dominated the LAMEA Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $47.6 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 6.3% during (2022 - 2028).
Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Herpes Simplex Virus Treatment Market is Projected to reach USD 2.1 Billion by 2028, at a CAGR of 3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Valacyclovir
- Acyclovir
- Famciclovir
By Type
- Herpes simplex virus-1 Infection
- Herpes simplex virus-2 Infection
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Pfizer, Inc.
- Amneal Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Fresenius SE & Co. KGaA
- Novartis AG
- Viatris, Inc.
- Emcure Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Herpes Simplex Virus Treatment Market, by Drug Type
1.4.2 LAMEA Herpes Simplex Virus Treatment Market, by Type
1.4.3 LAMEA Herpes Simplex Virus Treatment Market, by Distribution Channel
1.4.4 LAMEA Herpes Simplex Virus Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Herpes Simplex Virus Treatment Market by Drug Type
3.1 LAMEA Valacyclovir Market by Country
3.2 LAMEA Acyclovir Market by Country
3.3 LAMEA Famciclovir Market by Country
Chapter 4. LAMEA Herpes Simplex Virus Treatment Market by Type
4.1 LAMEA Herpes simplex virus-1 Infection Market by Country
4.2 LAMEA Herpes simplex virus-2 Infection Market by Country
Chapter 5. LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
5.1 LAMEA Drug Store & Retail Pharmacies Market by Country
5.2 LAMEA Hospital Pharmacies Market by Country
5.3 LAMEA Online Pharmacies Market by Country
Chapter 6. LAMEA Herpes Simplex Virus Treatment Market by Country
6.1 Brazil Herpes Simplex Virus Treatment Market
6.1.1 Brazil Herpes Simplex Virus Treatment Market by Drug Type
6.1.2 Brazil Herpes Simplex Virus Treatment Market by Type
6.1.3 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel
6.2 Argentina Herpes Simplex Virus Treatment Market
6.2.1 Argentina Herpes Simplex Virus Treatment Market by Drug Type
6.2.2 Argentina Herpes Simplex Virus Treatment Market by Type
6.2.3 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel
6.3 UAE Herpes Simplex Virus Treatment Market
6.3.1 UAE Herpes Simplex Virus Treatment Market by Drug Type
6.3.2 UAE Herpes Simplex Virus Treatment Market by Type
6.3.3 UAE Herpes Simplex Virus Treatment Market by Distribution Channel
6.4 Saudi Arabia Herpes Simplex Virus Treatment Market
6.4.1 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type
6.4.2 Saudi Arabia Herpes Simplex Virus Treatment Market by Type
6.4.3 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel
6.5 South Africa Herpes Simplex Virus Treatment Market
6.5.1 South Africa Herpes Simplex Virus Treatment Market by Drug Type
6.5.2 South Africa Herpes Simplex Virus Treatment Market by Type
6.5.3 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel
6.6 Nigeria Herpes Simplex Virus Treatment Market
6.6.1 Nigeria Herpes Simplex Virus Treatment Market by Drug Type
6.6.2 Nigeria Herpes Simplex Virus Treatment Market by Type
6.6.3 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel
6.7 Rest of LAMEA Herpes Simplex Virus Treatment Market
6.7.1 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type
6.7.2 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type
6.7.3 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Fresenius SE & Co. KGaA
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Viatris, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Research & Development Expense
7.10. Emcure Pharmaceuticals Limited
7.10.1 Company Overview
TABLE 1 LAMEA Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Valacyclovir Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Valacyclovir Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Acyclovir Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Acyclovir Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Famciclovir Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Famciclovir Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 12 LAMEA Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 13 LAMEA Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 LAMEA Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
TABLE 27 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 28 Brazil Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 29 Brazil Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 30 Brazil Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 31 Brazil Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 32 Brazil Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 33 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 36 Argentina Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 37 Argentina Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 38 Argentina Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 39 Argentina Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 40 Argentina Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 41 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 UAE Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 44 UAE Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 45 UAE Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 UAE Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 UAE Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 48 UAE Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 49 UAE Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 UAE Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 52 Saudi Arabia Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 60 South Africa Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 61 South Africa Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 62 South Africa Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 63 South Africa Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 64 South Africa Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 65 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Nigeria Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 68 Nigeria Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 69 Nigeria Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 70 Nigeria Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 71 Nigeria Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 72 Nigeria Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 73 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Rest of LAMEA Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 76 Rest of LAMEA Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 77 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 78 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 Key Information – Amneal Pharmaceuticals, INc.
TABLE 86 Key Information – GlaxoSmithKline PLC
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key Information – Glenmark Pharmaceuticals Limited
TABLE 89 key information – Fresenius SE & Co. KGaA
TABLE 90 Key Information – Novartis AG
TABLE 91 key information – Viatris, Inc.
TABLE 92 Key Information – Emcure Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories